• Explore /
  • Poster
  • / A phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: (JCOG1607 HERB TEA study).

A phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: (JCOG1607 HERB TEA study).

Abstract Poster

Authors

null

Akihiko Shimomura

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

Akihiko Shimomura , Kenji Tamura , Tomonori Mizutani , Taro Shibata , Fumikata Hara , Tomomi Fujisawa , Naoki Niikura , Takashi Hojo , Chizuko Kanbayashi , Shigehira Saji , Norikazu Masuda , Masataka Sawaki , Naohito Yamamoto , Fumio Nagashima , Tadahiko Shien , Hiroji Iwata

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

HER2-Positive

Clinical Trial Registration Number

UMIN000030783

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS1100)

DOI

10.1200/JCO.2019.37.15_suppl.TPS1100

Abstract #

TPS1100

Poster Bd #

181a

Abstract Disclosures

Similar Posters

First Author: Nicholas Patrick McAndrew

First Author: Julien Mazieres

First Author: Sayeh Moazami Lavasani

First Author: Yutaka Yamamoto